Project Main Details
• Audio files must be delivered via email
But which patients are at risk?
Baseline Ejection Fraction is the most powerful predictor of long-term mortality
Following a cardiac event, the risk of SCD is highest in the first 90 days.
The VALIANT Trial clearly demonstrated the high, early risk of SCD after an MI.
Numerous clinical studies show that
low-EF post-MI, post-PCI, and heart failure patients have high mortality in the early period following a cardiac event – including mortality from SCD.
High-risk Post-PCI patients have 90-day mortality rates ranging from 11 to 32 percent. As much as 60% of this mortality is due to SCD.
Post-MI patients with heart failure are at 4 to 6 times greater risk of SCD in the first 30 days after MI.
Mortality Rates in heart failure patients are high in the first six months following a diagnosis, with 54% due to SCD.
Bottom Line: In the early period after a cardiac event, Low-EF patients need protection from sudden cardiac death.
The LifeVest® wearable cardioverter defibrillator is a proven therapy for temporary protection of at-risk patients.
A prospective registry of 2,000 US patients assessed LifeVest outcomes
among ischemic, non-ischemic, and congenital heart failure patients.
A high rate of sustained VT/VF was experienced during a median wear time of 90 days.
The LifeVest protects patients during the vulnerable period
to determine if their EF will improve or if they will require long-term SCD protection.
Following use, LifeVest patients experience high one-year survival.
International cardiology societies recommend that the wearable defibrillator may be considered across a wide variety of patient types
including Post-MI, with or without revascularization,
newly diagnosed non-ischemic cardiomyopathy and heart failure, and other conditions for which an ICD is not appropriate.
On any given day, tens of thousands of people are protected from sudden cardiac death by wearing the LifeVest.
Prescribe the LifeVest. Together, we can identify patients at risk and prevent sudden cardiac death.
Voice123 Team Comments
Voice123 consultations with this voice seeker regarding this project and/or other projects by this voice seeker, via phone, chat, and/or email.
This project - phone.
Previous projects - phone.
This project - email or chat.
Previous projects - email or chat.
Note: Voice123 strives to establish the legitimacy of all projects posted. However, Voice123 subscribers and users are responsible for confirming information stated by prospective voice seekers, agents and/or clients. Voice123 subscribers and users assume all liability for use of any information found through Voice123, or any of its publications.
This page contains the most important details of this project. If you find the information on this project inaccurate or inappropriate, please let us know by contacting us.